Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-SWIFT: Zepatier and sofosbuvir in treatment-naive chronic HCV GT1 or GT3
NCT02133131Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of grazoprevir in hepatitis C (HCV), sponsored by Merck & Co.. Started Jun 2014; status: completed.
02
Drugs
grazoprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02133131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133131.